Companies in this category process cannabis and hemp from cultivators into finished products. This could include oils, concentrates, and various consumer-packaged goods.
Companies in this vertical hold or have applied for processing licences, which vary depending on the scale of operations and the location of the facility.
Processors can play a crucial role in moving cannabis and hemp products to market—from edibles to pharmaceuticals. They can also play a key role in fostering the horizontal integration that we think is necessary for the cannabis industry to mature.
Several factors may sharpen a processor’s competitive edge. We think successful processors will attempt to: maximize their extraction capacity, find ways to convert the most plant material into finished products, prioritize quick turnaround times,
and hone their technical expertise.
1Source: Grand View Research - “Cannabis Extract Market Size, Share & Trends Analysis Report” (2019)
2Source: Deloitte - “Nurturing New Growth - Canada Gets Ready for Cannabis 2.0” (2019)
This is not an offer to sell or a recommendation to trade in any securities. This information is provided as of the date hereof. This document contains data obtained from third parties that RIV Capital has not independently verified. This document also contains forward-looking information within the meaning of Canadian securities law, which is based on certain assumptions. While management believes these assumptions are reasonable based on information available as of the current date, they may prove to be incorrect. Many assumptions are based on factors outside of RIV Capital’s control and actual results may differ materially from current expectations. Forward-looking information involves risks, including, but not limited to, the risk factors set out in RIV Capital’s most recent Management’s Discussion and Analysis and Annual Information Form. You should not place undue reliance on forward-looking information. Except as required by applicable law, RIV Capital assumes no obligation to update or revise any forward-looking information to reflect new events or circumstances.
Please select how you would like to hear from RIV Capital:
We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.
Yes, I’m definitely at least twenty-one (21) years of age or am otherwise a qualified patient.